Sanjivani Paranteral Ltd (SANJIVIN) is currently trading at 157.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sanjivani Parenteral Limited is a WHO‑GMP certified pharmaceutical manufacturer focused on injectables, small volume parenterals and oral solids, operating two core WHO‑GMP manufacturing facilities and exporting to over 25 countries while growing its product basket to about 160 formulations through recent launches and strategic ventures. Q1 FY27 showed robust operational recovery: consolidated total income rose 33.8% YoY to ₹239.90 Mn, EBITDA improved 61.0% to ₹43.21 Mn with an 18.01% margin (305 bps improvement), and PAT increased 43.9% to ₹24.91 Mn, reflecting improved efficiencies and stronger export demand. Exports dominate the revenue mix, contributing 90.5% (₹176.10 Mn) in Q1 FY27, with core markets in Latin America, CIS, Middle East and Africa; injectables remain the largest segment, contributing 56.6% of product revenue, underlining the company’s strong geographic and product concentration in export markets and sterile formulations. Commercialization of the Pune IV Fluid facility and commissioning of a Prague nutraceuticals plant mark strategic diversification into IV fluids and European nutraceuticals; management emphasizes continued manufacturing capability strengthening, product portfolio expansion, and leveraging customer traction to drive sustainable growth.

Over the past 52 weeks, Sanjivani Paranteral Ltd has traded between a low of ₹126.00 and a high of ₹244.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sanjivani Paranteral Ltd has a market capitalization of approximately 187.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sanjivani Paranteral Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.16 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 187.70 Cr, Sanjivani Paranteral Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sanjivani Paranteral Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sanjivani Paranteral Ltd is 25.16. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The company reported consolidated profit after tax of ₹2.49 crore for the quarter ended June 30, 2026, up from ₹1.73 crore in Q1 FY26.